Our Transactions
Leadership across the largest and most complex situations
Financial Advisor
on its pending $22.5 billion
acquisition of
2024
Lead Financial Advisor
on its pending €8.0 billion
acquisition of
from Vodafone Group
2024
Exclusive Financial Advisor
on its pending ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its pending acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its pending ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its pending $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its pending ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Financial Advisor
on its up to $5.8 billion
acquisition of
2023
Lead Left Bookrunner
$300 million
Follow-on Offering
2023
Exclusive Financial Advisor
on its chapter 11 restructuring of ~$1.9 billion of debt and $125 million DIP ABL financing
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spinoff of
2021
Anouncement Date1
Status
Transaction
Value (M)
June 4, 2024
Pending
Advising 2-10 Home Buyers Warranty on its sale to Frontdoor
$585
May 29, 2024
Pending
Advising InsurEvo Group on its sale to NSM Insurance Group
N/A
May 29, 2024
Pending
Advising ConocoPhillips on its acquisition of Marathon Oil Corporation
$22,500
May 28, 2024
Closed
Advised 21 Invest France on its two-phase co-control sale and continuation fund transaction for Product Life Group
€500
May 24, 2024
Pending
Advising HPS Group on its acquisition of CR2
N/A
May 23, 2024
Pending
Advising KPS Capital Partners on its acquisition of Tate & Lyle’s remaining ownership interest in Primient
$350
May 22, 2024
Pending
Advising Cytokinetics on its strategic financing collaboration with Royalty Pharma
~$575
May 22, 2024
Closed
Advised SilverBow Resources on its successful proxy fight against Kimmeridge Energy Management Company
N/A
May 22, 2024
Pending
Acting as a Joint Bookrunner on GlobalFoundries’ Follow-on Offering
~$950
May 21, 2024
Pending
Advising SRG on its sale to Warburg Pincus and Temasek
N/A
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.